AFHSB supports NMRC Travelers' Diarrhea Study
Travelers’ diarrhea is the most common travel-related illness – affecting about 29 percent of troops per month on deployment to high risk regions.
THe Global Emerging Infections Surveillance section (GEIS) of the Armed Forces Health Surveillance Branch (AFHSB) have supported a Travelers' Diarrhea study by the Naval Medical Research Center (NMRC) to improve treatment for deployed U.S. and U.K. military troops. Spanning from 2012-2015, the clinical trial was conducted in four different regions of the world – Afghanistan, Djibouti, Honduras and Kenya. During November’s American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting in Atlanta, Georgia, November 13-17, NMRC researcher Capt. Mark Riddle had the opportunity to present the first results from the U.S. and U.K. collaborative Travelers’ Diarrhea treatment trial.
“We completed a randomized controlled trial to test three different antibiotic regimens to treat traveler’s diarrhea among deployed military members,” said Riddle. To learn about the main findings of the study, read Naval Medical Research Center’s December 2016 – Volume VIII, Issue 12 newsletter.